Icon

ENSACOVE (NDA218171)- (EQ 25MG BASE,EQ 100MG BASE)

ENSARTINIB HYDROCHLORIDE XCOVERY
EQ 25MG BASE,EQ 100MG BASE
No No
2037-Jun-01 2029-Dec-18
None None
None No
ENSACOVE is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not previously received an ALK-inhibitor.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 25MG BASE ** ** - - -
EQ 100MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.